Chinese police are investigating British drug firm GlaxoSmithKline (GSK) senior management staff in China for suspected “economic crimes,” according to a statement reported by Chinese state media yesterday.
Police in the central city of Changsha said they were investigating personnel of GlaxoSmithKline (China) Investment Co, the statement said.
Hong Kong’s South China Morning Post newspaper said police had detained company employees in three cities: Changsha, Shanghai and Beijing.
A spokeswoman for the company, which has its China headquarters in Shanghai, declined to comment, saying she was not authorized to speak to overseas media.
Internet postings, which could not be confirmed, said more than 10 police in plainclothes entered the GSK office in Shanghai on Thursday last week and seized account books.
The allegations involve at least one foreign executive employed by the company, said the postings on Chinese microblogs.
The exact nature of the allegations was not specified by Changsha police, but authorities typically use the phrase “economic crimes” when referring to corruption.
It is common practice for Chinese pharmaceutical firms to offer doctors and hospitals bribes to have their products used, industry insiders say.
GSK is one of the largest multinational pharmaceutical companies in China, with total investment of more than US$500 million, according to its Web site.
Last month, the company said data was “misrepresented” in a paper written by scientists at its Chinese research center and published in the journal Nature Medicine in 2010.
GSK sacked one of the people involved and placed three others on administrative leave, while another resigned, it said.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained